Clinical Trial Update: Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating thalidomide for advanced non-small cell lung cancer (Nsclc) is in an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Advanced Nsclc | Phase 2 | Status: UNKNOWN